AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Elekta

Transaction in Own Shares Feb 8, 2008

2906_rns_2008-02-08_7dad60ac-a17d-41ab-8f7d-3b66fc9ea779.pdf

Transaction in Own Shares

Open in Viewer

Opens in native device viewer

ELEKTA HAS REPURCHASED OWN SHARES FOR SEK 100 M

PRESS RELEASE

Stockholm, Sweden, February 8, 2008

During the period January 24 through February 8, 2008, Elekta has repurchased 951,300 B shares at an average price of SEK 105.11 totaling SEK 99,992,816.

These repurchases were carried out in line with the Board's decision on February 23, 2008, to mandate the executive management to initiate repurchase of shares in an amount of SEK 100 M.

Elekta's current holding of own shares (treasury stock) thereby amounts to 2,582,171 B shares.

The Annual General Meeting on September 25, 2007, resolved to cancel 1,630,871 of these shares and the cancellation process has started. The Board intends to propose to the next AGM that the recently repurchased 951,300 shares also should be cancelled.

The total number of shares in Elekta as of January 31, 2007 amounts to 93,903,316 divided between 3,562,500 A shares and 90,340,816 B shares.

******

For further information, please contact:

Peter Ejemyr, Group VP Corporate Communications, Elekta AB Tel: +46 733 611 000 (mobile), e-mail: [email protected]

About Elekta

Elekta is an international medical technology group, providing oncologists, radiation therapists, neurosurgeons and many other medical specialists with state of the art tools to fight serious disease.

Elekta provides advanced clinical solutions, comprehensive management and information systems as well as services for improved cancer care and management of brain disorders.

Elekta's systems and solutions are used in over 4,500 hospitals around the world. Clinical and information management solutions include, among others, Leksell Gamma Knife® for non-invasive treatment of brain disorders, Elekta Axesse™ and Elekta Synergy® for stereotactic and image guided radiation therapy and radiosurgery as well as the MOSAIQ™ suite of software for image-enabled EMR and efficient management of clinical and patient data.

With over 2,000 employees globally, the corporate headquarter is located in Stockholm, Sweden and the company is listed on the Nordic Exchange under the ticker EKTAb. More information about Elekta can be found at www.elekta.com.

Talk to a Data Expert

Have a question? We'll get back to you promptly.